REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cutia Therapeutics (科笛集团) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Cutia Therapeutics Profile Updated: February 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Cutia Therapeutics is a company that operates in the online casino and gambling industry. They offer a mobile app for Vulkan Vegas Casino and various betting services in Turkey. The company also focuses on research and development in dermatology, offering a range of solutions for skin and scalp diseases. They have a proprietary CATAME technology platform and a competitive product pipeline of creams, sprays, ointments, and aerosol foams.

Headquarters
20/F, Huanzhi Building, 436 Heng Feng Road, Jingan District
Shanghai; Shanghai;

Contact Details: Purchase the Cutia Therapeutics (科笛集团) report to view the information.

Website: http://www.cutiatx.com

Basic Information
Total Employees:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Outstanding Shares:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Registered Capital:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Financial Auditors:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Incorporation Date:
May 15, 2019
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
19.31%
Purchase this report to view the information.
18.91%
Purchase this report to view the information.
16.88%
Purchase this report to view the information.
12.38%
Purchase this report to view the information.
8.11%
Subsidiaries
Cutia Therapeutics (Hk) Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Cutia Therapeutics (科笛集团) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-30.64%▼
Total operating revenue
-26.36%▼
Operating Profit/Loss (EBIT)
-8.96%▼
EBITDA
-8.76%▼
Net Profit/Loss for the Period
-19.14%▼
Total Assets
-25.97%▼
Total Equity
-36.33%▼
Operating Profit Margin (ROS)
-128.59%▼
Net Profit Margin
-150.89%▼
Return on Equity (ROE)
-14.73%▼
Debt/Equity
16.16%▲
Quick Ratio
-1.9%▼
Cash Ratio
-0.36%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
HBM Holdings Limited
 
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Sailong Pharmaceutical Group Co.,Ltd.
 
Hunan Nucien Pharmaceutical Co., Ltd.
MedSci Healthcare Holdings Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo